Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Stock

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Transplantation|February 17, 2017
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in DirectionPhilip J OʼConnell, Dirk R Kuypers, Roslyn B Mannon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2018
Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Transplantation|March 13, 2018
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders WorkshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Diabetes Care|May 22, 2016
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe HypoglycemiaBernhard J Hering, William R Clarke, Nancy D Bridges, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 7, 2020
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetesJames F Markmann, Michael R Rickels, Thomas L Eggerman, et al.
Diabetes Care|June 23, 2012
Improvement in outcomes of clinical islet transplantation: 1999-2010Franca B Barton, Michael R Rickels, Rodolfo Alejandro, et al.
Diabetes|July 29, 2016
National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing FacilitiesCamillo Ricordi, Julia S Goldstein, A N Balamurugan, et al.
Diabetes|July 1, 2017
Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428Camillo Ricordi, Julia S Goldstein, A N Balamurugan, et al.
Transplantation|August 11, 2018
Oxygen Perfusion (Persufflation) of Human Pancreata Enhances Insulin Secretion and Attenuates Islet Proinflammatory SignalingAmy C Kelly, Kate E Smith, William G Purvis, et al.
JCI Insight|March 12, 2026
Human antibody repertoire among kidney donors with and without HIVXianming Zhu, William R Morgenlander, Diane M Brown, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Transplantation|February 17, 2017
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in DirectionPhilip J OʼConnell, Dirk R Kuypers, Roslyn B Mannon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2018
Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Transplantation|March 13, 2018
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders WorkshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Diabetes Care|May 22, 2016
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe HypoglycemiaBernhard J Hering, William R Clarke, Nancy D Bridges, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 7, 2020
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetesJames F Markmann, Michael R Rickels, Thomas L Eggerman, et al.
Diabetes Care|June 23, 2012
Improvement in outcomes of clinical islet transplantation: 1999-2010Franca B Barton, Michael R Rickels, Rodolfo Alejandro, et al.
Diabetes|July 29, 2016
National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing FacilitiesCamillo Ricordi, Julia S Goldstein, A N Balamurugan, et al.
Diabetes|July 1, 2017
Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428Camillo Ricordi, Julia S Goldstein, A N Balamurugan, et al.
Transplantation|August 11, 2018
Oxygen Perfusion (Persufflation) of Human Pancreata Enhances Insulin Secretion and Attenuates Islet Proinflammatory SignalingAmy C Kelly, Kate E Smith, William G Purvis, et al.
JCI Insight|March 12, 2026
Human antibody repertoire among kidney donors with and without HIVXianming Zhu, William R Morgenlander, Diane M Brown, et al.
Pageof 13